Search Tag: cancer
2023 09 May
As a leader in women’s health, Hologic knows that increasing access to breast cancer screening is critical to detecting cancer earlier and saving lives. We commend the U.S. Preventive Services Task Force (USPSTF) for changing their draft guidelines to recommend that women begin screening at age 40. Lowering the age for initial screening to 40...Read more
2022 01 Mar
Innovative rhPSMA Theranostic technology has the potential to offer both diagnostic imaging and treatment for patients affected by prostate cancer. Blue Earth Therapeutics has exclusive worldwide rights to therapeutic applications of radiohybrid Prostate-Specific Membrane Antigen (rhPSMA) radiopharmaceutical technology. “ We are increasingly...Read more
2017 16 Sep
Hologic, Inc. is deeply concerned that the United States Preventive Services Task Force (USPSTF) did not include a grade for co-testing (also known as Pap+HPV Together) in draft cervical cancer screening recommendations released this week. These draft recommendations do not consider the wealth of data supporting the value of co-testing, and will put...Read more